{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:38Z","timestamp":1786118678413,"version":"build-2736575974"},"reference-count":52,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"HIPRA SCIENTIFIC, S.L.U"},{"name":"Centre for the Development of Industrial Technology"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2474775","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T22:55:07Z","timestamp":1746053707000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5714-0125","authenticated-orcid":false,"given":"Mar\u00eda Jes\u00fas","family":"L\u00f3pez","sequence":"first","affiliation":[{"name":"Hospital Regional Universitario de M\u00e1laga","place":["M\u00e1laga, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5571-0582","authenticated-orcid":false,"given":"Maria Del Mar","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Hospital Regional Universitario de M\u00e1laga","place":["M\u00e1laga, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchor","family":"Alvarez-Mon","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Hospital Universitario Pr\u00edncipe de Asturias","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9450","authenticated-orcid":false,"given":"Jos\u00e9 Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[{"name":"La Paz University Hospital, IdiPAZ","place":["Madrid, Spain"]},{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9759-333X","authenticated-orcid":false,"given":"Eunate","family":"Arana-Arri","sequence":"additional","affiliation":[{"name":"Scientific Coordinator, Biocruces Bizkaia Health Research Institute, Osakidetza, Barakaldo, Spain.g. Clinical Microbiology, Infectious Diseases and AIDS Group, Instituto de Investigaci\u00f3n Sanitaria Hospital Gregorio Mara\u00f1on","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-5583","authenticated-orcid":false,"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"CIBER Enfermedades Respiratorias, CIBERES Group (CB06\/06\/0058)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Navarro-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario de Valencia","place":["Valencia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ramos","sequence":"additional","affiliation":[{"name":"Vascular Health Research Group, Institut Universitari d\u2019Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria Jordi Gol (IDIAP Jordi Gol), Biomedical Research Institute, Girona (IdIBGi), Catalan Institute of Health","place":["Catalonia, Spain"]},{"name":"University of Girona","place":["Girona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4564-1963","authenticated-orcid":false,"given":"Jos\u00e9","family":"Molto","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Fundaci\u00f3 Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol","place":["Badalona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-568X","authenticated-orcid":false,"given":"Susana","family":"Otero-Romero","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona","place":["Barcelona, Spain"]},{"name":"Universitat Aut\u00f2noma de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Aurrecoechea","sequence":"additional","affiliation":[{"name":"University of Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc","family":"Pomarol","sequence":"additional","affiliation":[{"name":"University of Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8137-640X","authenticated-orcid":false,"given":"Laia","family":"Bernad","sequence":"additional","affiliation":[{"name":"Irsicaixa","place":["Badalona, Spain"]},{"name":"Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Esteban","sequence":"additional","affiliation":[{"name":"University of Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-5958","authenticated-orcid":false,"given":"Ra\u00fal","family":"P\u00e9rez-Caballero","sequence":"additional","affiliation":[{"name":"Irsicaixa","place":["Badalona, Spain"]},{"name":"Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-4329","authenticated-orcid":false,"given":"Montserrat","family":"Plana","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"University of Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-4645","authenticated-orcid":false,"given":"J\u00falia G.","family":"Prado","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Irsicaixa","place":["Badalona, Spain"]},{"name":"Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-0811","authenticated-orcid":false,"given":"\u00c1lex","family":"Soriano","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101052"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9050331"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12020135"},{"key":"e_1_3_6_5_1","unstructured":"WHO. Coronavirus (COVID-19) dashboard [internet]. Who.int. [accessed 2023 Oct 18]. https:\/\/covid19.who.int\/."},{"key":"e_1_3_6_6_1","unstructured":"Our World in Data. Cumulative confirmed COVID-19 cases and deaths. [accessed 2023 Oct 18]. https:\/\/ourworldindata.org\/grapher\/cumulative-deaths-and-cases-covid-19."},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2206573"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118946"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31057-1"},{"key":"e_1_3_6_10_1","unstructured":"European Medicines Agency (EMA). ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines [internet]. News; 2022 [accessed 2023 Oct 18]. https:\/\/www.ema.europa.eu\/en\/news\/ecdc-ema-update-recommendations-additional-booster-doses-mrna-covid-19-vaccines."},{"key":"e_1_3_6_11_1","unstructured":"US Department of Health and Human Services; Office of Infectious Disease. HIV\/AIDS Policy (OIDP). Vaccine types. 2021. [accessed 2023 Oct 18]. https:\/\/www.hhs.gov\/immunization\/basics\/types\/index.html."},{"key":"e_1_3_6_12_1","unstructured":"World Health Organization. COVID-19 vaccine tracker and landscape. Who.int. [access 2023 Oct 18]. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.37201\/req\/046.2023"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100613"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100253"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02183-8"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.972083"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076990"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2213948"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167955"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115481"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.018"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00816-7"},{"key":"e_1_3_6_26_1","unstructured":"Organizaci\u00f3n Mundial de la Salud. ARNm prote\u00ednas adenovirus \u00bfc\u00f3mo act\u00faa y en qu\u00e9 se diferencia cada tipo de vacuna. Vacunaci\u00f3n COVID-19 Gobierno de Espa\u00f1a. [accessed 2023 Oct 18]. https:\/\/www.vacunacovid.gob.es\/arnm-proteinas-adenovirus-como-actua-y-en-que-se-diferencia-cada-tipo-de-vacuna."},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00578-z"},{"key":"e_1_3_6_28_1","unstructured":"Centers for Disease Control and Prevention. Adjuvants and Vaccines [Internet]. Vaccine Safety. 2023 [accessed 2023 Apr 14]. https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/adjuvants.html#:~:text=Newer. adjuvants have been developed is stronger and lasts longer."},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2018.08.070"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80541-5"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80162-3"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017011411"},{"key":"e_1_3_6_33_1","volume-title":"EMA recommends approval of Bimervax as a COVID-19 booster vaccine","author":"European Medicines Agency","year":"2023","unstructured":"European Medicines Agency. EMA recommends approval of Bimervax as a COVID-19 booster vaccine. News; 2023 [accessed 2023 Oct 18]. https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-bimervax-covid-19-booster-vaccine."},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106126"},{"key":"e_1_3_6_35_1","unstructured":"EMEA. BIMERVAX EPAR- Product information. 2023. [accessed 2023 Oct 18]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bimervax-epar-product-information_en.pdf."},{"key":"e_1_3_6_36_1","unstructured":"Healthcare Products Regulatory Agency. Bimervax COVID-19 vaccine authorised by MHRA. [accessed 2023 Oct 18]. https:\/\/www.gov.uk\/government\/news\/bimervax-covid-19-vaccine-authorised-by-mhra."},{"key":"e_1_3_6_37_1","unstructured":"World Health Organization. Vaccines. [accessed 2023 Oct 18]. https:\/\/extranet.who.int\/prequal\/vaccines."},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126685"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.26502\/acbr.50170414"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2023.01.020"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1054557"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2021.01.005"},{"key":"e_1_3_6_43_1","volume-title":"Guidance for industry. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials","author":"FDA","year":"2007","unstructured":"FDA. Guidance for industry. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2007. https:\/\/www.fda.gov\/media\/73679\/download."},{"key":"e_1_3_6_44_1","unstructured":"FDA. Centre for biologics evaluation and research. 2007. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-data-needed-support-licensure-seasonal-inactivated-influenza-vaccines."},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02467-4"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01676-0"},{"key":"e_1_3_6_47_1","volume-title":"EMA and ECDC recommendations on heterologous vaccination courses against COVID-19","author":"European Medicines Agency (EMA)","year":"2021","unstructured":"European Medicines Agency (EMA). EMA and ECDC recommendations on heterologous vaccination courses against COVID-19. News; 2021. https:\/\/www.ecdc.europa.eu\/en\/news-events\/ema-and-ecdc-recommendations-heterologous-vaccination-courses-against-covid-19."},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00650-3"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107659"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.09.037"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2206711"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.4103\/0972-6748.328833"},{"key":"e_1_3_6_53_1","volume-title":"Poster in: 17th Vaccine Congress","author":"De Cambra S","year":"2023","unstructured":"De Cambra S, Moros A, Barreiro A. Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects. Preliminary results of HIPRA-HH-2 extension study. Poster in: 17th Vaccine Congress; 2023 Sep 24\u201327; Glasgow."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2474775","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2474775","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2474775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:41:34Z","timestamp":1786034494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2474775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2474775"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2474775","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2474775"}}